| 15d-PGJ2 | 15-deoxy-Δ12,14-prostaglandin J2 |
| 5-FU | fluorouracil |
| AF | activation function |
| AgRC | agonist–receptor complex |
| AnRC | antagonist–receptor complex |
| AIF | apoptosis-inducing factor |
| ALT | alanine aminotransferase |
| ALPI | alkaline phosphatase |
| AMPK | AMP-activated protein kinase |
| AP1 | activator protein 1 |
| BAX | BCL2-associated X protein |
| Bcl | B-cell lymphoma proteins (Bcl-2 and Bcl-xL) |
| BRAF | B-rapidly accelerated fibrosarcoma |
| BRCA1 | breast cancer gene 1 |
| cAMP | cyclic adenosine monophosphate |
| CAF | cancer-associated fibroblasts |
| CASP1 | caspase 1 |
| CAT | catalase |
| CBP | CREB-binding protein |
| CCL2 | C-C motif chemokine ligand 2 |
| CCND1 | cyclin D1 |
| CD | complex of differentiation |
| CDK5 | cyclin-dependent kinase 5 |
| c-FLIP | flice-inhibitory protein |
| CHK2 | checkpoint kinase 2 |
| CGZ | ciglitazone |
| CNS | central nervous system |
| CCND1 | cyclin D1 |
| COX2 | cyclooxygenase 2 |
| CTL | cytotoxic lymphocyte |
| CTLA | cytotoxic T-lymphocyte antigen |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| DBD | DNA-binding domain |
| DC | dendritic cell |
| DHA | docosahexanoic acid |
| DOPA | 3,4-dihydroxyphenylalanine |
| DOPA enzyme | tyrosine hydroxylase |
| DR | death receptor |
| DTIC | dacarbazine |
| ECM | extracellular matrix |
| EFZ | multidrug resistance 1 |
| EGF | epidermal growth factor |
| EGFR | epidermal growth factor receptor |
| eIF2 | eukaryotic initiation factor 2 |
| EPA | eicosopentanoic acid |
| ERK1/2 | extracellular signal-regulated kinases ½ |
| FABP4 | fatty acid-binding protein 4 |
| FAK | focal adhesion kinase |
| FDA | Food and Drug Administration |
| FOS | this protein name originates from Finkel–Biskis–Jinkins (FBJ) murine osteosarcoma virus |
| GPX | glutathione peroxidase |
| GSK-3β | glycogen synthase kinase-3β |
| HCC | hepatocellular carcinoma |
| HDAC3 | histone deacetylase 3 |
| HIF1 α | hypoxia-inducible factor 1α |
| HMOX1 | heme oxygenase-1 |
| IFNG | interferon γ |
| IGF1 | insulin-like growth factor 1 |
| IGFBP3 | insulin growth factor-binding protein 3 |
| IGF1 | insulin growth factor 1 |
| IKK-α | inhibitor of nuclear factor κB kinase subunit α |
| JNK | c-Jun N-terminal kinase |
| JUN | this protein name originates from “ju-nana”, the Japanese word for “17”,じゅうなな, (e.g., a viral oncogene v-jun means the seventeenth viral oncogene in English) |
| KLRG1 | killer cell lectin-like receptor subfamily G member 1 |
| LAG3 | lymphocyte-activation gene 3 |
| LBD | ligand-binding domain |
| LC-PUFA | long-chain polyunsaturated fatty acid |
| LXR | liver X receptor |
| MAPK | mitogen-activated protein kinase |
| MC1R | melanocortin-1 receptor |
| MCAD1 | medium-chain acyl-CoA dehydrogenase |
| MDR1 | multidrug resistance 1 |
| MDSC | myeloid-derived suppressor cell |
| MHC1 | major histocompatibility complex class I |
| MITF | microphthalmia-associated transcription factor |
| α-MSH | α-melanocyte-stimulating hormone |
| mTOR | mechanistic target of rapamycin |
| NCoA | nuclear receptor coactivator |
| NCoR | nuclear receptor corepressor |
| NFκB | nuclear factor κB |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| NSCLC | non-small cell lung cancer |
| NYHA | New York Heart Association |
| Octa | 2,4,6-octatrienoic acid |
| O-GlcNAc | β-O-linked N-acetylglucosamine |
| p70S6K | p70 ribosomal S6 kinase |
| PDGF | platelet-derived growth factor |
| PDK4 | pyruvate dehydrogenase kinase 4 |
| PD-L1 | programmed death ligand 1 |
| PERK | protein kinase RNA-like endoplasmic reticulum kinase |
| PGC-1α | PPAR-γ coactivator-1α |
| PGC-1β | PPAR-γ coactivator-1β |
| PGZ | pioglitazone |
| PI3K | phosphoinositide 3-kinase |
| PKA | protein kinase A |
| PKB | protein kinase B |
| PKC | protein kinase C |
| PKR | protein kinase RNA-activated |
| PLA2 | phospholipase A2 |
| PLC | phospholipase C |
| PPAR-α | peroxisome proliferator-activated receptor α |
| PPAR-β/δ | peroxisome proliferator-activated receptor β/δ |
| PPAR-γ | peroxisome proliferator-activated receptor γ |
| PPRE | peroxisome proliferator response element |
| PTEN | phosphatase and tensin homolog deleted on chromosome 10 |
| PUFA | polyunsaturated fatty acid |
| RB1 | retinoblastoma 1 |
| RGZ | rosiglitazone |
| ROS | reactive oxygen species |
| RXR- α | retinoid X receptor α |
| SHC | Src homology and collagen |
| SMAD2 | mothers against decapentaplegic homolog 2 |
| SMRT | silencing mediator of retinoid and thyroid hormone receptors |
| SNP | single-nucleotide polymorphism |
| SOD | superoxide dismutase |
| SRC | sarcoma family member |
| STAT3 | signal transducer and activator of transcription 3 |
| T2D | type 2 diabetes |
| TAM | tumor-associated macrophage |
| TetO | tetracycline operator |
| TGF-β | transforming growth factor-β |
| TIM3 | T-cell immunoglobulin and mucin domain-3 |
| TME | tumor microenvironment |
| TNF-α | tumor necrosis factor-α |
| TP53 | tumor protein p53 |
| TRAIL | TNF-related apoptosis-inducing ligand |
| Treg | regulatory T cell |
| TRPM1 | transient receptor potential melastatin 1 |
| TRP1 | tyrosinase-related protein-1 |
| TRP2 | tyrosinase-related protein-2 |
| TZD | thiazolidinedione |
| TYR | tyrosinase |
| VCAM1 | vascular cell adhesion molecule 1 |
| VDR | vitamin D receptor |
| VEGF | vascular endothelial growth factor |
| VILL1 | villin 1 |
| WNT | wingless-related integration site |